Update, November 6, 2026
Since the November 3 report, BG rose 3.0% over five days, closing at $99.565 on November 6, while the S&P 500 fell 2.4% and XLP gained 0.8% — the stock outperformed its sector by 2.3 percentage points over that stretch. The bounce follows the Q3 earnings beat on October 29, when adjusted EPS of $2.56 topped last year's $2.27 and the company maintained full-year guidance of $9.25–$9.75, per The Motley Fool. A November 3 SEC 8-K disclosed a material agreement and financial obligation, adding to the news flow.
The picture holds. The stock remains below its 40-week average, and the daily trend still runs with the weekly downtrend. The 5-day gain has not broken the key resistance at $100.00 (round), where sellers have appeared on rallies; the close at $99.565 sits just under that level. The downside breakout level from the assessment — a daily close below $90.00 — is unchanged, as is the 52-week low support at $88.55. The stop at $100.75 (round plus a quarter of ATR) and the level that would change the picture — a weekly close above $104.08 (swing zone) — also remain intact. Relative weakness persists: BG lags the S&P 500 by 5.3% and XLP by 14.1% over 50 days. The RSI at 39.85 is no longer extreme, but the trend and structure still favor the bearish stance.
Bunge Global SA (BG) beat third-quarter earnings estimates on October 29, 2026, yet the stock has kept sliding and trades at $94.63, 13% below its October 14 peak. For the next two to six weeks the balance of evidence leans negative, with high conviction: the daily trend runs with the weekly downtrend, and BG trails both the S&P 500 and consumer staples. An RSI near 11 shows how stretched the fall is, but oversold is not a reversal.
Why it matters
The quarter was good on the headline. Adjusted EPS came in at $2.56 against $2.27 a year earlier, ahead of a consensus of roughly $2.42 to $2.44, and Reuters credited strong soybean and oilseed crush margins. The 10-Q shows revenue of $5.45 billion, up 25%, and net income of $318 million, up 92%. Management kept full-year adjusted EPS guidance at $9.25 to $9.75, but Seeking Alpha notes it raised the net interest expense outlook to $640 million to $670 million.
The market's first response was a shrug. Investing.com reported shares down 0.11% premarket as higher interest costs and elevated working capital offset the beat. A beat that fails to lift the stock suggests the good news was already in the price, and the stock had been weakening before the report. It peaked at $108.91 on October 14 and is down 10.9% over one month and 23.7% over six months. It still shows a 6.8% gain for the year, but that trails the S&P 500's 10.5%. Price sits below both the 50-day average at $109.93 and the 200-day at $117.03. Volume today is 15% under its 20-day average, so the drift lower is not coming with a surge of selling.
Over five days BG fell 6.1% while the S&P 500 fell 2.1% and the consumer staples ETF (XLP) rose 2.4%. Against its own sector the stock is 8.6 points behind, so the market explains only part of the fall and the sector went the other way. Over a month XLP is up 10.8% while BG is down 10.9%, which points to money rotating into defensives and passing over this one. The news in hand does not fully explain the continued slide after a beat. The closest explanation is Bloomberg, which describes record diesel prices and uneven agricultural exports adding uncertainty for crop traders, with Bunge calling the global landscape challenging.
No articles in the debate set argue a side on BG, so the argument has to be read from the company's own numbers. The positive case is crush economics: adjusted EBIT rose to $846 million from $757 million, as the earnings call transcript shows, and guidance was held. The negative case is that financing costs are rising and working capital is heavy. Tropical oils and grain merchandising also declined within a segment result that was otherwise driven by soybean and softseed processing. On valuation, nine analysts rate the stock a buy with a mean price target of $139.22 and a range of $116 to $155. The stock is 32% below that mean and below even the lowest target. Such a gap says the analysts and the market disagree, and it does not say who is right.
What the evidence says
The long-term thesis is weakened and the stock is in a downtrend phase. Price is below its 40-week average and its 10-week average. It is 28% under the 52-week high of $131.41 and only 6.9% above the 52-week low of $88.55. The 50-day average has also fallen under the 200-day. Earnings have not been the problem. The problem is that nothing in the quarter gave buyers a reason to step in at higher prices.
For the next two to six weeks the balance of evidence leans negative, and conviction is high at 3 of 4 points. The daily trend runs with the weekly downtrend. BG lags the S&P 500 by 12.4% over 50 days and lags XLP by 18.3%. Those are three independent confirmations that the stock is the weak part of a market where defensives are winning.
The strongest case against this reading is the oversold condition. An RSI of 11.03 is an extreme, the earnings beat was real, and the price is far below every analyst target. Light volume also means the decline lacks the heavy selling that often marks a final low. Stocks in this state can bounce sharply. But oversold readings can persist in a downtrend, and a bounce would still meet sellers at the first resistance. That fourth point not being met is why conviction is high rather than maximum.
Levels that matter
In a downtrend the structure holds below $97.9, a swing zone where sellers have shown up on earlier rallies. Above it come $100 and the swing zone at $102.72, where the weekly trend would end on a weekly close above. Higher up are $104.08 and the 50-day average at $109.93. Below the price, support sits at $90, then the 52-week low of $88.55, then $80.
The breakout level is a daily close below $90.0. From there the only target in the map is $88.55, the 52-week low. Against a stop at $98.66, which is $97.9 plus a quarter of the 3.05 average daily range, the reward-to-risk is 0.2 to 1. That is far short of the 3 to 1 that makes a breakout worth the risk. Only a target well below $88.55 would change that, and even $80 would fall short against that stop.
What would change the picture
A weekly close above $102.72 would end the weekly downtrend and be the first sign that buyers are back. The non-price fact that would do it is evidence that the earnings pressure is easing: a raise to the $9.25 to $9.75 full-year adjusted EPS range, or a lower interest expense outlook than $640 million to $670 million.
What to watch
- Earnings: the quarter was reported on October 29, 2026, and the data has no next date yet. The number that matters is the full-year adjusted EPS guidance of $9.25 to $9.75, together with net interest expense against the $640 million to $670 million outlook.
- Sector events: consumer staples moved opposite to BG over the past month, so a turn in XLP would matter as much as company news. Diesel costs and agricultural export flows, as Bloomberg describes, hit crop traders ahead of BG's own news. The longer-run backdrop is a MarketsandMarkets forecast of edible oils growing 4.8% a year to $351.08 billion by 2031, which is slow-moving and not a trigger.
- Valuation: at $94.63 the stock is 32% below the $139.22 mean target and below the $116 low, so the consensus is far above where the market trades.